Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD

Koichi Takahashi, Hagop Kantarjian, Naveen Pemmaraju, Michael Andreeff, Gautam Borthakur, Stefan Faderl, Guillermo Garcia-Manero, Sherry Pierce, Rajyalakshmi Luthra, Marylou Cardenas-Turanzas, Zeev Estrov, Farhad Ravandi, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD'. Together they form a unique fingerprint.

Medicine & Life Sciences